Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06287866 · ClinicalTrials.gov registry record · NA
Pinch Grafting Versus Second Intention Wound Healing for Mohs Micrographic Surgery Defects on the Scalp
A NA study of Scarring, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06287866: Recruiting NA study of Scarring, sponsored by University of California, Davis.
NCT06287866 is a NA study of Scarring that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 50 participants, below the 77-participant average among 8 other Scarring trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06287866, a NA study of Scarring, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Oftentimes, following surgery on the scalp, wounds are left to heal by themselves. This is called "second intention." Open wounds left to heal on the scalp often take 8 weeks or more to completely heal. The investigators are investigating how second intention closure compares to another established reconstruction technique, called "pinch graft." In the pinch graft technique, a dermatological surgeon numbs and then shaves off a thin piece of skin (usually from the groin area) and places it in the wound bed it (also known as "grafting"), to encourage growth of new healthy skin. This study will compare time-to-healing in the second intention method versus the pinch graft method.
Primary Outcome
Participants will submit weekly photos to blinded reviewers to assess for re-epithelization.
Conditions Studied
Interventions
- PROCEDURE Pinch Graft
Study Locations (1)
California
- University of California, Davis - Dermatology Department - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-04-02 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT06287866 shows while recruiting
NCT06287866 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 77-participant average among 8 other Scarring trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Scarring appearing as the primary indexed condition, and to 1 intervention - of which Pinch Graft is the first listed.
NCT06287866 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06287866 about?
NCT06287866 is a clinical study titled "Pinch Grafting Versus Second Intention Wound Healing for Mohs Micrographic Surgery Defects on the Scalp". Oftentimes, following surgery on the scalp, wounds are left to heal by themselves. This is called "second intention." Open wounds left to heal on the scalp often take 8 weeks or more to completely heal. The investigators are investigating how second intention closure compares to another established ...
What is the current status of trial NCT06287866?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-04-02. Estimated completion is 2026-12-01.
What conditions does trial NCT06287866 study?
This clinical trial studies the following conditions: Scarring.
What interventions are being tested in trial NCT06287866?
The interventions under investigation include: Pinch Graft (PROCEDURE).
Who is sponsoring clinical trial NCT06287866?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06287866 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Scarring
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06287866's enrollment target sits among peer trials
50 6th of 8 higher than 2 of 8 other Scarring trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Scarring trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Outcomes of Running Locking Suture vs Standard Running Suture in Surgical Wounds
RECRUITING · NA
-
Aesthetic Outcome of Intra-dermal Versus Transcutaneous Purse-string Closure
RECRUITING · NA
-
Aesthetic Outcome of Tie-over Bolster Application in Surgical Wounds
RECRUITING · NA
-
Amniotic Membrane in Total Knee Replacements to Reduce Scarring
COMPLETED · NA
-
dHACM in Lumbar Decompression and Microdiscectomy Surgery
COMPLETED · NA
-
Treatment of Hypopigmented Scars With Bimatoprost
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI